| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 325 | $19.83 | $6,446.18 | -0.2% | +19.6% | +29.6% | |
| Feb 27, 2024 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 843 | $386.46 | $325,785.78 | -73.9% | +3.8% | +50.3% | |
| Feb 27, 2024 | INSP Inspire Medical Systems, Inc. | Ban Randy68 | Chief Commercial Officer | Sell | 15,290 | $184.70 | $2,824,025.70 | -71.6% | -14.6% | +6.3% | |
| Feb 27, 2024 | AVTR Avantor, Inc. | Bramwell James70 | EVP Sales, Customer Excellence | Sell | 6,203 | $24.49 | $151,911.47 | -5.8% | -2.9% | -29.5% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Tyrs Florian | VP, Global Operations | Sell | 893 | $20.27 | $18,103.07 | -3.9% | +16.6% | +27.0% | |
| Feb 26, 2024 | MXCT Maxcyte, Inc. | Johnston John Joseph75 | Director | Sell | 5,000 | $4.60 | $23,005.00 | -4.0% | +6.4% | -20.3% | |
| Feb 26, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 13,396 | $1.25 | $16,714.19 | - | -27.2% | -39.0% | |
| Feb 26, 2024 | BSX Boston Scientific Corp | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sell | 9,335 | $67.07 | $626,098.45 | -24.4% | +12.7% | +51.1% | |
| Feb 26, 2024 | ATEC Alphatec Holdings, Inc. | Hunsaker Craig E61 | EVP, People &Culture | Sell | 41,560 | $15.05 | $625,478.00 | -3.4% | -31.9% | -30.0% | |
| Feb 26, 2024 | STIM Neuronetics, Inc. | Sullivan Keith J61 | President And CEO | Sell | 20,292 | $3.30 | $66,963.60 | -1.5% | -36.8% | +31.6% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 3,048 | $20.27 | $61,786.31 | -1.9% | +16.6% | +27.0% | |
| Feb 26, 2024 | TCMD Tactile Systems Technology Inc | Burns Kristie60 | Sr. VP Mktg &Clinical Affairs | Sell | 4,264 | $15.32 | $65,326.58 | -3.5% | -18.3% | -5.8% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Green Andrew M | VP Regulatory | Sell | 2,403 | $20.27 | $48,711.45 | -2.8% | +16.6% | +27.0% | |
| Feb 26, 2024 | AORT Artivion, Inc. | MacKin James P53 | President &CEO | Sell | 31,312 | $20.27 | $634,728.68 | -2.3% | +16.6% | +27.0% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 3,514 | $20.27 | $71,232.65 | -1.1% | +16.6% | +27.0% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 2,880 | $20.27 | $58,380.77 | -0.9% | +16.6% | +27.0% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Maney Rochelle L. | VP, Quality | Sell | 2,315 | $20.27 | $46,927.60 | -2.7% | +16.6% | +27.0% | |
| Feb 26, 2024 | TCMD Tactile Systems Technology Inc | Reuvers Daniel L.67 | President And CEO | Sell | 11,617 | $15.37 | $178,497.37 | -2.6% | -18.3% | -5.8% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 2,166 | $20.27 | $43,907.20 | -0.8% | +16.6% | +27.0% | |
| Feb 26, 2024 | AORT Artivion, Inc. | Getz Matthew A | VP, Human Resources | Sell | 2,313 | $20.27 | $46,887.05 | -2.6% | +16.6% | +27.0% | |
| Feb 23, 2024 | EW Edwards Lifesciences Corp | Gallahue Kieran | Director | Sell | 3,058 | $87.61 | $267,911.38 | -4.4% | -0.3% | -16.5% | |
| Feb 23, 2024 | QDEL Quidelortho Corp | Busky Joseph M | Chief Financial Officer | Buy | 2,150 | $46.36 | $99,663.25 | New | -10.7% | -13.7% | |
| Feb 23, 2024 | GKOS Glaukos Corp | Foley Mark J | Director | Sell | 4,560 | $92.87 | $423,487.20 | -12.1% | +20.0% | +40.5% | |
| Feb 23, 2024 | UFPT Ufp Technologies Inc | Feldmann Cynthia L55 | Director | Sell | 1,724 | $207.77 | $358,192.00 | -11.0% | +17.3% | +20.9% | |
| Feb 23, 2024 | RGEN Repligen Corp | Bylund James70 | Chief Operating Officer | Sell | 4,373 | $198.08 | $866,203.84 | -23.6% | -19.2% | -19.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.